Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.57 |
| ▸ | P2RY2 | P41231 | 7/20 | 0.32 |
| ▸ | P2RY1 | P47900 | 6/20 | 0.32 |
| ▸ | POLG | P54098 | 2/20 | 0.32 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.32 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16698714 | 0.86 | POLRMT (0.65) | POLRMTP2RY2P2RY1POLGP2RY11 | |
| SCHEMBL16698713 | 0.86 | POLRMT (0.65) | POLRMTP2RY2P2RY1POLGP2RY11 | |
| SCHEMBL20960138 | 0.86 | POLRMT (0.65) | POLRMTP2RY2P2RY1POLGP2RY11 | |
| SCHEMBL24942352 | 0.81 | POLRMT (0.52) | POLRMTP2RY2P2RY1POLGP2RY11 | |
| SCHEMBL20960074 | 0.79 | POLRMT (0.59) | POLRMTP2RY2P2RY1POLGP2RY11 | |
| SCHEMBL16708598 | 0.78 | POLRMT (0.64) | POLRMTP2RY2P2RY1P2RY11P2RY4 | |
| SCHEMBL19101783 | 0.76 | POLRMT (0.48) | POLRMTP2RY2P2RY1POLGP2RY11 | |
| SCHEMBL20756116 | 0.74 | POLRMT (0.44) | POLRMTP2RY2P2RY1POLGP2RY11 | |
| SCHEMBL19779220 | 0.73 | POLRMT (0.85) | POLRMTP2RY2P2RY1P2RY11 | |
| SCHEMBL16699057 | 0.73 | POLRMT (0.85) | POLRMTP2RY2P2RY1P2RY11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3068405-B1 | PYRROLO [1,2,F][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | GILEAD SCIENCES INC (US) | 2019-05-01 | — | — | EP | disclosed |